ckd semaglutide just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in semaglutide ckd without diabetes Semaglutides

About Sodium and Health

Indirect Effects: Reduced Food Cravings Leading to Reduced Drinking Opportunities In addition to reduced reward from consuming alcohol while on GLP-1s, slow appetite or reduced appetite may also prevent one from wanting to drink alcohol

The most wonderful chart in the book [highlights] that people all over the world universally, are spending more time helping people that they will never meet

Our providers will create a custom weight loss plan tailored to your specific needs and preferences

In the United States, regulatory oversight from the FDA and consumer protection from the FTC place similar expectations on the separation between factual reporting and promotional content